Observed arrival · 2026-11-03
Prizume makes stock-price assumptions legible—and publishes its misses
A stock-valuation and teaching tool that uses SEC filings to show what future cash-flow growth a company’s share price appears to assume.
- For
- Students learning company valuation
- Worth noticing
- Its own test says cheap-versus-expensive verdicts did not predict returns; it also flags survivor bias in the sample.
Field notes
The valuation example expresses Apple's price as an implied 15% annual cash-flow growth rate over ten years, then compares that assumption with 6.4% growth from 2016 to 2025. Prizume reports that its own cheap-or-expensive verdict did not predict three-year returns, and notes that its company sample leans toward winners because the companies are still large today. Its sample forecast illustrates a range, confidence estimate, and digital fingerprint.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue